The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Management of opioid use disorders: a national clinical practice guideline
Open accessAbstract
[See related article at [www.cmaj.ca/lookup/doi/10.1503/cmaj.180209][2]][2] KEY POINTS Opioid use disorder is one of the most challenging forms of addiction facing the Canadian health care system, and a major contributor to the marked rises in opioid-related morbidity and death that Canada has been
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816
Going from evidence to recommendations
Guyatt, G. H., Oxman, A. D., Kunz, R., Falck-Ytter, Y., Vist, G. E., Liberati, A., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39493.646875.ae · Cited by 1,810
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
D’Onofrio, G., O’Connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S. H., Owens, P. H., Bernstein, S. L., & Fiellin, D. A. (2015) · JAMA · doi:10.1001/jama.2015.3474 · Cited by 910
Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., & McLaren, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03140.x · Cited by 856
Alonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., et al. (2016) · BMJ · doi:10.1136/bmj.i2089 · Cited by 814
Kampman, K., & Jarvis, M. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000166 · Cited by 678
Weiss, R. D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.121 · Cited by 540
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
Uchtenhagen, A. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-17408 · Cited by 490
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub4 · Cited by 419
Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004147.pub4 · Cited by 370
Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients: A Randomized Clinical Trial
Liebschutz, J. M., Crooks, D., Herman, D., Anderson, B., Tsui, J., Meshesha, L. Z., Dossabhoy, S., & Stein, M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.2556 · Cited by 342
Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study
Strang, J., McCambridge, J., Best, D., Beswick, T., Bearn, J., Rees, S., & Gossop, M. (2003) · BMJ · doi:10.1136/bmj.326.7396.959 · Cited by 339
Schünemann, H. J., Al-Ansary, L. A., Forland, F., Kersten, S., Komulainen, J., Kopp, I. B., Macbeth, F., Phillips, S. M., Robbins, C., van der Wees, P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1885 · Cited by 337
McCance‐Katz, E. F., Sullivan, L. E., & Nallani, S. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00005.x · Cited by 318
Lapse and relapse following inpatient treatment of opiate dependence.
Smyth, B. P., Barry, J., Keenan, E., & Ducray, K. (2010) · PubMed · Cited by 298
Gossop, M., Stewart, D., Browne, N., & Marsden, J. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00227.x · Cited by 284
Fairbairn, N., Coffin, P. O., & Walley, A. Y. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.005 · Cited by 274
Alpha2-adrenergic agonists for the management of opioid withdrawal
Gowing, L., Farrell, M., Ali, R., & White, J. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002024.pub5 · Cited by 271
Kraus, M. L., Alford, D. P., Kotz, M. M., Levounis, P., Mandell, T. W., Meyer, M., Salsitz, E. A., Wetterau, N., & Wyatt, S. A. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3182312983 · Cited by 266
Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi, S., Amato, L., Bellisario, C., Ferri, M., & Davoli, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub3 · Cited by 262
Medication-Assisted Treatment With Methadone: Assessing the Evidence
Fullerton, C. A., Kim, M., Thomas, C. P., Lyman, D. R., Montejano, L. B., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300235 · Cited by 251
Opioid agonist treatment for pharmaceutical opioid dependent people
Nielsen, S., Larance, B., Degenhardt, L., Gowing, L., Kehler, C., & Lintzeris, N. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011117.pub2 · Cited by 249
Lofwall, M. R., & Walsh, S. L. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000045 · Cited by 248
Zedler, B. K., Mann, A. L., Kim, M. M., Amick, H. R., Joyce, A. R., Murrelle, E. L., & Jones, H. E. (2016) · Addiction · doi:10.1111/add.13462 · Cited by 240
Bonhomme, J., Shim, R. S., Gooden, R., Tysu, D., & Rust, G. (2012) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30175-9 · Cited by 233
Maintenance agonist treatments for opiate dependent pregnant women
Minozzi, S., Amato, L., Vecchi, S., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub2 · Cited by 225
Methadone at tapered doses for the management of opioid withdrawal
Amato, L., Davoli, M., Minozzi, S., Ferroni, E., Ali, R., & Ferri, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003409.pub4 · Cited by 222
Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
Thomas, C. P., Fullerton, C. A., Kim, M., Montejano, L., Lyman, D. R., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300256 · Cited by 208
Kakko, J., Grönbladh, L., Svanborg, K. D., von Wachenfeldt, J., Rück, C., Rawlings, B., Nilsson, L.-H., & Heilig, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.797 · Cited by 197
Treatment of opioid-dependent pregnant women: Clinical and research issues
Jones, H. E., Martin, P. R., Heil, S. H., Kaltenbach, K., Selby, P., Coyle, M. G., Stine, S. M., O'Grady, K. E., Arria, A. M., & Fischer, G. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.10.007 · Cited by 191
Self-citationDeaths Attributable to Methadone vs Buprenorphine in France
Auriacombe, M. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.1.45 · Cited by 191
Fiellin, D. A., Schottenfeld, R. S., Cutter, C. J., Moore, B. A., Barry, D. T., & O’Connor, P. G. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5302 · Cited by 184
Comparing overdose mortality associated with methadone and buprenorphine treatment
Bell, J. R., Butler, B., Lawrance, A., Batey, R., & Salmelainen, P. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.03.020 · Cited by 182
Bruneau, J., Roy, É., Arruda, N., Zang, G., & Jutras‐Aswad, D. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03803.x · Cited by 171
Self-citationBuprenorphine for managing opioid withdrawal
Gowing, L., Ali, R. L., White, J. M., & Mbewe, D. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002025.pub5 · Cited by 168
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub3 · Cited by 157
Pierce, M., Bird, S., Hickman, M., Marsden, J., Dunn, G., Jones, A., & Millar, T. (2015) · Addiction · doi:10.1111/add.13193 · Cited by 155
Weiss, R. D., Potter, J. S., Griffin, M. L., Provost, S. E., Fitzmaurice, G. M., McDermott, K. A., Srisarajivakul, E., Dodd, D. R., Dreifuss, J. A., McHugh, R. K., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.02.030 · Cited by 152
Hypogonadism in men receiving methadone and buprenorphine maintenance treatment
Hallinan, R., Byrne, A., Agho, K., McMahon, C. G., Tynan, P., & Attia, J. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00824.x · Cited by 124
A systematic review of the cardiotoxicity of methadone.
Alinejad, S., Kazemi, T., Zamani, N., Hoffman, R. S., & Mehrpour, O. (2015) · EXCLI journal · doi:10.17179/excli2015-553 · Cited by 113
Alpha2 adrenergic agonists for the management of opioid withdrawal
Gowing, L., Farrell, M., Ali, R. L., & White, J. M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002024.pub2 · Cited by 110
Beck, T., Haasen, C., Verthein, U., Walcher, S., Schuler, C., Backmund, M., Ruckes, C., & Reimer, J. (2013) · Addiction · doi:10.1111/add.12440 · Cited by 102
Rosado, J., WALSH, S. L., Bigelow, G. E., & Strain, E. C. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.04.006 · Cited by 101
Marsch, L. A., Moore, S. K., Borodovsky, J. T., Solhkhah, R., Badger, G. J., Semino, S. J., Jarrett, K., Condon, K. A. D., Rossettie, K., Vincent, P., et al. (2016) · Addiction · doi:10.1111/add.13363 · Cited by 101
The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight
Eibl, J. K., Morin, K. A., Leinonen, E., & Marsh, D. C. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717711167 · Cited by 100
Cost and utilization outcomes of opioid-dependence treatments.
Başer, O., Chalk, M., Fiellin, D. A., et al. (2011) · PubMed · Cited by 98
Methadone at tapered doses for the management of opioid withdrawal
Amato, L., Davoli, M., Minozzi, S., Ali, R. L., & Ferri, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003409.pub3 · Cited by 95
Safe Methadone Induction and Stabilization: Report of an Expert Panel
Baxter, L. E., Campbell, A., DeShields, M., Levounis, P., Martin, J. A., McNicholas, L. F., Payte, J. T., Salsitz, E. A., Taylor, T., & Wilford, B. B. (2013) · Journal of Addiction Medicine · doi:10.1097/01.adm.0000435321.39251.d7 · Cited by 88
Post-marketing Surveillance of Methadone and Buprenorphine in the United States
Dasgupta, N., Bailey, E. J., Cicero, T. J., Inciardi, J. A., Parrino, M. W., Rosenblum, A., & Dart, R. C. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00877.x · Cited by 82
Marteau, D., McDonald, R., & Patel, K. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007629 · Cited by 82
Slow-release oral morphine as maintenance therapy for opioid dependence.
Ferri, M., Minozzi, S., Bo, A., & Amato, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009879.pub2 · Cited by 74
Comparison of costs and utilization among buprenorphine and methadone patients
Barnett, P. G. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02539.x · Cited by 73
Amass, L. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00141-1 · Cited by 71
Boone, M., Brown, N. J., MOON, M. A., Schuman, D. J., Thomas, J. S., & Wright, D. (2004) · Cited by 69
McCance‐Katz, E. F., Rainey, P. M., Smith, P. F., Morse, G. D., Friedland, G., Gourevitch, M. N., & Jatlow, P. L. (2004) · American Journal on Addictions · doi:10.1080/10550490490436037 · Cited by 65
Krantz, M. J., Garcia, J. A., & Mehler, P. S. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.4.611.61020 · Cited by 63
Unobserved “Home” Induction Onto Buprenorphine
Lee, J. D., Vocci, F. J., & Fiellin, D. A. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000059 · Cited by 62
Opioid dependence and pregnancy: minimizing stress on the fetal brain
McCarthy, J. J., Leamon, M. H., Finnegan, L. P., & Fassbender, C. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.003 · Cited by 62
At-a-glance - Hospitalizations and emergency department visits due to opioid poisoning in Canada
O’Connor, S., Grywacheski, V., & Louie, K. (2018) · Health Promotion and Chronic Disease Prevention in Canada · doi:10.24095/hpcdp.38.6.04 · Cited by 61
Maremmani, I., & Gerra, G. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00086.x · Cited by 59
Tuten, M., DeFulio, A., Jones, H. E., & Stitzer, M. L. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03750.x · Cited by 59
Hämmig, R., Köhler, W., Bonorden‐Kleij, K., Weber, B., Lebentrau, K., Berthel, T., Babic-Hohnjec, L., Vollmert, C., Höpner, D., Gholami, N., et al. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.05.012 · Cited by 56
Slow‐release oral morphine for opioid maintenance treatment: a systematic review
Jegu, J., Gallini, A., Soler, P., Montastruc, J., & Lapeyre‐Mestre, M. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03923.x · Cited by 50
Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme
Tjagvad, C., Skurtveit, S. O., Línnet, K., Andersen, L. V., Christoffersen, D. J., & Clausen, T. (2016) · European Addiction Research · doi:10.1159/000446429 · Cited by 49
Is methadone too dangerous for opiate addiction?
Luty, J. S., OʼGara, C., & Sessay, M. (2005) · BMJ · doi:10.1136/bmj.331.7529.1352 · Cited by 44
Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy
Noormohammadi, A., Forinash, A. B., Yancey, A. M., Crannage, E. F., Campbell, K., & Shyken, J. M. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016648367 · Cited by 43
Indicators of Buprenorphine and Methadone Use and Abuse: What Do We Know?
Maxwell, J. C., & McCance‐Katz, E. F. (2009) · American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00008.x · Cited by 40
Fareed, A., Patil, D., Scheinberg, K., Gale, R. B., Vayalapalli, S., Casarella, J., & Drexler, K. P. G. (2013) · Journal of Addictive Diseases · doi:10.1080/10550887.2013.824333 · Cited by 39
FRANCES, R. J. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2012.07.108 · Cited by 39
Yee, A., Loh, H. S., Hashim, H. M. B. H., & Ng, C. (2014) · International journal of impotence research · doi:10.1038/ijir.2014.18 · Cited by 38
Mannelli, P., Peindl, K., Lee, T., Bhatia, K. S., & Wu, L.-T. T. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205010052 · Cited by 38
Hadland, S. E., DeBeck, K., Kerr, T., Feng, C. X., Montaner, J. S. G., & Wood, E. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005419 · Cited by 38
Self-citationTrends and sex differences in prescription opioid deaths in British Columbia, Canada
Gladstone, E. J., Smolina, K., & Morgan, S. G. (2015) · Injury Prevention · doi:10.1136/injuryprev-2015-041604 · Cited by 38
Verthein, U., Beck, T., Haasen, C., & Reimer, J. (2014) · European Addiction Research · doi:10.1159/000368572 · Cited by 36
Puzhko, S., Roy, É., Jutras‐Aswad, D., Artenie, A. A., Fortier, E., Zang, G., & Bruneau, J. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.027 · Cited by 36
Self-citationMcCance‐Katz, E. F., Rainey, P. M., Smith, P. F., Morse, G. D., Friedland, G. H., Boyarsky, B. K., Gourevitch, M. N., & Jatlow, P. I. (2006) · American Journal on Addictions · doi:10.1080/10550490500419029 · Cited by 36
Lankenau, S. E., Kecojević, A., & Silva, K. (2014) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2014.970515 · Cited by 31
Slow-release oral morphine as maintenance therapy for opioid dependence
Ferri, M., Minozzi, S., Amato, L., Bò, A., & Davoli, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009879 · Cited by 31
Chronic Use of Opioids and the Endocrine System
Merza, Z. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1254099 · Cited by 27
Luty, J. S. (2003) · Advances in Psychiatric Treatment · doi:10.1192/apt.9.4.280 · Cited by 27
Falcato, L., Beck, T., Reimer, J., & Verthein, U. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000288 · Cited by 27
Holland, R., Maskrey, V., Swift, L., Notley, C. J., Robinson, A., Nagar, J., Gale, T., & Kouimtsidis, C. (2013) · Addiction · doi:10.1111/add.12439 · Cited by 26
Methadone patients in the therapeutic community: A test of equivalency
Sorensen, J. L., Andrews, S., Delucchi, K., Greenberg, B., Guydish, J. R., Masson, C. L., & Shopshire, M. S. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.09.009 · Cited by 25
Methadone-induced torsades de pointes: A twist of fate
Thanavaro, K. L., & Thanavaro, J. L. (2011) · Heart & Lung · doi:10.1016/j.hrtlng.2010.12.008 · Cited by 22
Moody, D. E. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.783567 · Cited by 21
Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
Parks, C. L., Fullerton, C. A., Kim, M. L., Montejano, L. B., Lyman, D. R., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130309 · Cited by 18
Methadone Maintenance Therapy in Residential Therapeutic Conmmunity Settings: Challenges and Promise
Greenberg, B., Hall, D. H., & Sorensen, J. L. (2007) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2007.10400606 · Cited by 14
Residential Treatment Modifications: Adjunctive Services to Accommodate Clients on Methadone
Chen, T., Masson, C. L., Sorensen, J. L., & Greenberg, B. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802647495 · Cited by 6
Opioid Dependence and Pregnancy: Minimizing Stress on the Fetal Brain
McCarthy, J. J., Leamon, M. H., Finnegan, L. P., et al. (2017) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000527018.02135.42 · Cited by 2
Cited by
Treatment of stimulant use disorder: A systematic review of reviews
Ronsley, C., Nolan, S., Knight, R., Hayashi, K., Klimas, J., Walley, A., Wood, E., & Fairbairn, N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234809 · Cited by 222
Self-citationCrotty, K., Freedman, K. I., & Kampman, K. M. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000635 · Cited by 95
Rice, D., Corace, K., Wolfe, D., Esmaeilisaraji, L., Michaud, A., Grima, A., Austin, B., Douma, R., Barbeau, P., Butler, C., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244401 · Cited by 64
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02445-4 · Cited by 51
Raines, A. M., Allan, N. P., McGrew, S. J., Gooch, C. V., Wyatt, M., Laurel Franklin, C., & Schmidt, N. B. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106285 · Cited by 22
Metadata
- Authors
- Bruneau, J., Ahamad, K., Goyer, M.-È., Poulin, G., Selby, P., Fischer, B., Wild, T. C., & Wood, E.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2018-03-04
- Volume
- 190
- Issue
- 9
- Pages
- E247-E257
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2791607419
- Cited by
- 412
- References
- 95
- FWCI
- 44.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.